# Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

> **NCT01324635** · PHASE1 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 17 (actual)

## Conditions studied

- Recurrent Glioma
- High-grade Meningioma
- Brain Metastasis

## Interventions

- **DRUG:** Panobinostat
- **RADIATION:** Stereotactic body radiation therapy
- **PROCEDURE:** Quality-of-life assessment
- **RADIATION:** Stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT01324635
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2013-10
- **Final completion:** 2016-10
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Arm A - reached goal; Arm B - poor accrual
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324635, "Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01324635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*